+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Myelodysplastic Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Myelodysplastic Syndrome Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Influenza Vaccines Market Report 2023-2033 - Product Thumbnail Image

Influenza Vaccines Market Report 2023-2033

  • Report
  • October 2023
  • 192 Pages
  • Global
From
From
From
From
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 500 Pages +
  • Global
From
Stem Cell Therapy Market - Global Forecast 2025-2032 - Product Thumbnail Image

Stem Cell Therapy Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 186 Pages
  • Global
From
Leukemia Therapeutics Market Report 2025 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Nocturia Market - Global Forecast 2025-2030 - Product Thumbnail Image

Nocturia Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
From
The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024 - Product Thumbnail Image

The Global Exosome Market: Size, Forecast, Trials, and Trends, 2024

  • Report
  • September 2024
  • 351 Pages
  • Global
From
From
From
Loading Indicator